Advertisement

Topics

Latest "Challenge" News Stories - Page: 3

05:50 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Challenge" found in our extensive news archives from over 250 global news sources.

More Information about Challenge on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Challenge for you to read. Along with our medical data and news we also list Challenge Clinical Trials, which are updated daily. BioPortfolio also has a large database of Challenge Companies for you to search.

Showing "Challenge" News Articles 51–75 of 1,300+

Relevant

£30 Million global cardiovascular disease challenge – now open for applications

Call for the world’s greatest minds to tackle the world’s biggest killers  The British Heart Foundation’s Big Beat Challenge is now accepting proposals London, UK, 24th January 2019 / Sciad Newswire / The British Heart Foundation (BHF) is today calling for researchers and innovators from around the world to apply for one of the largest research grants of its kind in history. 


$VXRT New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart’s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity https://www.businesswire.com/news/home/20181004005175/en/New-Data-Phase-2-Flu-Challenge-Study …

$VXRT New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart’s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity https://www.businesswire.com/news/home/20181004005175/en/New-Data-Phase-2-Flu-Challenge-Study …

Cell Therapy Manufacturing: The Supply Chain Challenge

The success of cell therapies hinges on not only proving that a product elicits the desired biological response, but also overcoming the challenges of manufacturing and administering a complex product to any patient. The post Cell Therapy Manufacturing: The Supply Chain Challenge appeared first on GEN - Genetic Engineering and Biotechnology News.


Pfizer Decides Not To Challenge AbbVie's Humira Biosimilar Patents

Pfizer is the seventh company to enter licensing agreement with AbbVie; it has completed development program for its adalimum...

Probably Relevant

Social Determinants Data Project Wins Indiana Tech Challenge

David Raths, Contributing EditorA project involving social determinants of health data from Regenstrief Institute and the Indiana University Richard M. Fairbanks School of Public Health at IUPUI took home the top prize in the inaugural Indiana Inject Tech Challenge from BioCrossroads.

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

This paper was originally published by Toon van der Gronde, Carin A. Uyl-de Groot, and Toine Pieters in PLoS ONE 12(8): e0182613 under a creative commons license. Abstract Context Recent public outcry… The post Addressing the challenge of high-priced p... The post Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycle...

Do’s and Dont’s for effective “lightening” demos of your health IT product

I’ll be moderating the the first of 3 “Innovator’s Challenge” sessions at the Partners 2012 Connected Health Symposium & Expo. It’s not easy for a company to be selected for a prestigious demo session like this and if the demos are done right they can help the company gain traction in the market. The Innovator’s Challenge sessions use the “lightening” format where each partici...

International Freezer Challenge 2019: Environmental protection at -80°C

Global warming is a challenge for mankind on earth. Sustainability discussions primarily focus on energy consumption of devices. Even environmentally friendly and energy efficient ultra-low temperature freezers traditionally consume a large amount of energy as they maintain extremely low temperatures 24 hours a day, 7 days a week, for years. The International Institute for Sustainable Laboratories...

£30m global cardiovascular challenge launched

British Heart Foundation to tackle the suffering and devastation caused by heart and circulatory diseases with historic research award London, UK, 25th August 2018 / Sciad Newswire / The British Heart Foundation (BHF) is today launching the Big Beat Challenge, a unique research funding award that will bring together world-leading researchers and innovators to identify and solve any of the bigge...

British Heart Foundation Launches £30M Big Beat Challenge Award

The British Heart Foundation (BHF) has launched a £30 million global cardiovascular research award, The Big Beat Challenge, which is calling leading researchers, entrepreneurs, inventors, and industry to come together and collaborate on tackling a key facet of any one of the major cardiac and circulatory diseases that kill an estimated 18 million people in the world every year. Launched y...

Sandoz Healthcare Access Challenge #SandozHACk Returns, Seeking Digital Solutions to Local Healthcare Access Challenges

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global competition that invites entrepreneurs and innovators in the field of digital technology to submit inspirational ideas with the potential to complement - or even positively disrupt - established approaches to driving access to healt...

Novo Nordisk Launches the Innovation Challenge Focused on Diabetes Management

Novo Nordisk, a global leader in the diabetes space, is seizing the opportunity to advance care and leverage digital health technology through the Novo Nordisk Innovation Challenge. With support from MATTER, a prominent incubator and innovation hub, Novo Nordisk is challenging start-ups, researchers, entrepreneurs, and students to explore, design; and co-develop digital health solutions for the ....

Medtech Rises To Challenge Of Meeting Infinite Heath Care Demand With Finite Resources

The relative absence of blockbuster M&A within medtech in 2018, compared with recent years, does not mean that consolidation of...    

#Karuna pharma takes on a challenge most companies have avoided: making a better schizophrenia drug https://www.bostonglobe.com/business/2019/01/10/boston-biotech-takes-challenge-most-companies-have-avoided-making-better-schizophrenia-drug/xObUVQPjm0JJ9Tr

#Karuna pharma takes on a challenge most companies have avoided: making a better schizophrenia drug https://www.bostonglobe.com/business/2019/01/10/boston-biotech-takes-challenge-most-companies-have-avoided-making-better-schizophrenia-drug/xObUVQPjm0JJ9TrrBcTlMK/story.html …

News Digest #250 – P&G biomaterials challenge, synthetic neurobiology, and more

  Your guide to what’s new in synthetic biology Hi all, As I think about the future of synthetic biology and what 2019 has in store, I remain convinced that partnerships are critical to the future of our field. Fostering fruitful partnerships and collaborations is one of my main goals at SynBioBeta. Read how Procter […] The post News Digest #250 – P&G biomaterials chall...

A Constitutional Challenge to Alaska’s Genetic Privacy Statute

As part of its defense of a class action lawsuit that began in 2014, a genetic genealogy company (or DNA ancestry company as they are sometimes called) is challenging the constitutionality of the Alaska Genetic Privacy Act, arguing that the statute’s provisions are unconstitutionally vague. The State of Alaska is intervening in the lawsuit to […] The post A Constitutional Challenge to Alas...

Andy Robertson reveals the dressing room key to Liverpool’s title challenge – Liverpool Echo

Andy Robertson reveals the dressing room key to Liverpool's title challenge Liverpool EchoIf defences win titles, Man City have shown it may be Liverpool's year Evening StandardCeltic fans react to Virgil van Dijk display for Liverpool HITCGary Neville says Manchester United game made him realise Fabinho was a ‘top player' GIVEMESPORTTop at Christmas? We might need 105 points – Klopp Four...

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

Ongoing challenge

The competition change that benefits Liverpool’s Premier League title challenge – Liverpool Echo

The competition change that benefits Liverpool's Premier League title challenge Liverpool EchoManchester City v Liverpool: Pick your combined XI BBC SportWhich Premier League clubs are best placed to qualify for the Champions League? Daily MailBernardo Silva accepts pressure is on Manchester City for Liverpool clash The GuardianPremier League predictions: Lawro v Yatez BBC SportView full cove...

The challenge of the post-truth era

Andrew Robertson says honesty and frankness key to Liverpool’s place at top of table – The Telegraph

Andrew Robertson says honesty and frankness key to Liverpool's place at top of table The TelegraphCeltic fans react to Virgil van Dijk display for Liverpool HITCIf defences win titles, Man City have shown it may be Liverpool's year Evening StandardAndy Robertson reveals the dressing room key to Liverpool's title challenge Liverpool EchoJurgen Klopp sets Chelsea and Spurs a major challenge in '...

STAT Plus: With schizophrenia drug results, Alkermes gets much-needed good news. But insurers could pose challenge

With new clinical trial results on its schizophrenia drug, Alkermes gets much-needed good news. But insurers could pose a challenge.

The Pancreatic Cancer Collective awards $7 million in 'New Therapies Challenge' grants

(Stand Up To Cancer) The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and SU2C, has awarded a total of $7 million in first-round 'New Therapies Challenge' grants to seven teams to explore new pancreatic cancer treatments, each receiving up to $1 million in initial funding. After research is reviewed in 14 months, $4 million per team for clinical studies awai...

Trying To Recruit Programmers? Here's What They Really Want

Value them, challenge them, and set them free.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks